Company Filing History:
1 out of 3 
1 out of 13 Years Active: 2016
Title: Leyre Uriguen: Innovator in Neuropsychiatric Research
Introduction
Leyre Uriguen is a distinguished inventor based in Bizkaia, Spain, with a notable focus on neuropsychiatric illness research. With a single patent to his name, Uriguen has significantly contributed to the field of neuroscience through inventive solutions that hold promise for improving therapeutic methodologies.
Latest Patents
Uriguen's patent, "STXBP1 overexpressing mouse and its uses in screening of treatments for neuropsychiatric illness," describes a non-human transgenic animal engineered to express the STXBP1 polypeptide at levels greater than wild-type in specific brain regions. This innovative work not only includes the creation of related vectors and methods for producing transgenic animals but also outlines various screening methods for potential therapeutic agents. Furthermore, it encompasses methods for treating and diagnosing neuropsychiatric illnesses, showcasing Uriguen’s commitment to advancing medical research.
Career Highlights
Throughout his career, Leyre Uriguen has worked with prominent organizations such as Brainco Biopharma, S.L. and the University of the Basque Country (Universidad Del País Vasco - Euskal Herriko Unibertsitatea). These affiliations have allowed him to collaborate on pioneering research and develop impactful inventions that address critical issues in neuropsychiatry.
Collaborations
Uriguen has had the privilege of working alongside esteemed colleagues, including Maria Jose Guerrero Martinez and Laureano Simon Buela. Their collaborative efforts have contributed to his innovative research and the successful development of his patent, reflecting a strong network of professionals dedicated to the advancement of neuropsychiatric treatment options.
Conclusion
In summary, Leyre Uriguen’s work exemplifies the intersection of innovation and medical research. His developments in transgenic models for neuropsychiatric illness not only enhance our understanding of such conditions but also pave the way for future therapeutic interventions. As he continues his career, it will be exciting to see how his inventions influence the landscape of neuropsychiatry and beyond.